Ticker
LCTXCompany Name
LINEAGE CELL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 42.27M | 3.93 | $ 10.76M |
3/31/2025 | $ 47.89M | 3.66 | $ 13.09M |
12/31/2024 | $ 45.79M | 3.28 | $ 13.98M |
9/30/2024 | $ 27.75M | 2 | $ 13.86M |
6/30/2024 | $ 29.62M | 1.94 | $ 15.28M |
3/31/2024 | $ 43.58M | 2.58 | $ 16.89M |
12/31/2023 | $ 35.44M | 1.97 | $ 17.96M |
9/30/2023 | $ 31.47M | 1.98 | $ 15.88M |
6/30/2023 | $ 33.89M | 2.11 | $ 16.05M |
3/31/2023 | $ 15.45M | 0.9 | $ 17.23M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for LINEAGE CELL THERAPEUTICS INC is calculated as follows: CashnEq [ $ 32.56M ] / LiabilitesC [ $ 7.75M ]
(=) Cash Ratio [ 4.2 ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |